Cimpress Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cimpress (CMPR).

Price Target Range — 11 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOutperform# Analysts2Avg. Consensus PT$111Upside to Avg. PT+47.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 31, 2026	Truist Securities	Youssef Squali	PT Cut	Buy	$110→$108
May 6, 2026	Barrington Research	Kevin Steinke	PT Raise	Outperform	$95→$113
Feb 2, 2026	Barrington Research	Kevin Steinke	PT Raise	Outperform	$83→$95
Jan 27, 2026	Barrington Research	Kevin Steinke	Maintained	Outperform	$83
Nov 17, 2025	Barrington Research	Kevin Steinke	PT Raise	Outperform	$77→$83
Oct 1, 2025	Barrington Research	Kevin Steinke	PT Raise	Outperform	$70→$77
Sep 17, 2025	Truist Securities	Youssef Squali	PT Raise	Buy	$74→$78
Aug 4, 2025	Barrington Research	Kevin Steinke	PT Raise	Outperform	$65→$70
Jul 30, 2025	Truist Securities	Youssef Squali	PT Raise	Buy	$60→$74
Jul 29, 2025	Barrington Research	Kevin Steinke	Maintained	Outperform	$65
May 9, 2025	Barrington Research	Kevin Steinke	PT Cut	Outperform	$95→$65
May 5, 2025	Truist Securities	Youssef Squali	PT Cut	Buy	$87→$60
Jan 31, 2025	Truist Securities	Youssef Squali	PT Cut	Buy	$110→$87
Jan 31, 2025	Barrington Research	Kevin Steinke	PT Cut	Outperform	$119→$95
Jan 29, 2025	Barrington Research	Kevin Steinke	Maintained	Outperform	$119
Dec 20, 2024	Barrington Research	Kevin Steinke	Maintained	Outperform	$119
Nov 1, 2024	Truist Securities	Youssef Squali	PT Cut	Buy	$120→$110
Aug 27, 2024	Barrington Research	Kevin Steinke	PT Raise	Outperform	$113→$119
Aug 2, 2024	Truist Securities	Youssef Squali	PT Raise	Buy	$110→$120
May 28, 2024	Barrington Research	Kevin Steinke	Maintained	Outperform	$113

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and lowers the price target from $110 to $108.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $95 to $113.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $83 to $95.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and maintains $83 price target.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $83

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $77 to $83.

Benzinga Newsdesk

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Cimpress PLC

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Cimpress Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

PRO
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $83

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

People Also Watch

People Also Watch

Cimpress PLC

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Cimpress Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

PROBarrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

PROBarrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

PROBarrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

PROBarrington Research Maintains Outperform on Cimpress, Raises Price Target to $83

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

PRO
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $83